Press Releases

Email Alerts

May 31, 2018

Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that the...
May 31, 2018

Hong Yu Appointed President of Biostage

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, has elected Hong Yu as...
May 25, 2018

Dr. Wei Zhang Elected to Biostage's Board of Directors

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that Dr....
- Photos 1
May 10, 2018

Biostage Reports 2018 First Quarter Financial Results

- Steady progress in the new year signals strengthening financial and technology positions

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced its...
May 4, 2018

Biostage to Host Conference Call to Discuss First Quarter 2018 Financial Results and Operations

- Conference Call with Live Audio Webcast on Thursday, May 10th at 9:00 AM ET -

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...

Show per page